News Summary
The Digital Medicine Society (DiMe) has launched a new project called ‘Scaling Trusted, High-Impact AI Care Navigation’ to improve the use of AI in healthcare. Announced on January 9, 2026, the initiative aims to address challenges in patient navigation and enhance healthcare accessibility. With Intel as a Title Sponsor and various organizations joining as partners, the project focuses on implementing effective AI tools to help patients manage their health journeys more efficiently.
Boston, MA – Leading healthcare and technology organizations are coming together to advance the responsible use of artificial intelligence (AI) in patient care navigation, a critical step towards improving healthcare accessibility and outcomes nationwide. The Digital Medicine Society (DiMe), a global non-profit, recently launched a new initiative titled “Scaling Trusted, High-Impact AI Care Navigation” to address how patients are increasingly using AI tools to manage their health journeys.
Announced on January 9, 2026, this multi-stakeholder project brings together experts from various sectors, including technology, healthcare delivery, patient advocacy, life sciences, and policy. The initiative aims to accelerate the adoption of trusted, AI-enabled care navigation systems at scale, moving beyond pilot programs to widespread implementation. Intel is a key Title Sponsor for this endeavor, alongside a broad coalition of founding partners.
Addressing the Patient Navigation Crisis with AI
The new initiative directly responds to the growing trend of patients independently utilizing AI to navigate their complex care needs. It acknowledges the existing challenges within patient navigation, often referred to as a “patient navigation crisis,” where individuals struggle to understand their health information and the fragmented healthcare system. By focusing on care navigation, DiMe aims to address one of the most immediate and impactful areas for patients.
The initiative seeks to define clear standards and gather credible evidence on how AI-enabled navigation performs in real-world care settings, for diverse patients, and under practical constraints. This focus aligns with the broader goal of making AI a legitimate and trustworthy partner in the patient care journey.
A Collaborative and Comprehensive Approach
The “Scaling Trusted, High-Impact AI Care Navigation” initiative is built upon DiMe’s foundational work, specifically its AI in Healthcare Playbook. This playbook serves as a practical roadmap for AI adoption and scaling within U.S. care delivery, having been utilized by hundreds of healthcare organizations. The new project will leverage the high-value AI use cases identified in the playbook to guide its efforts.
Beyond Intel, other prominent organizations have joined as founding partners, demonstrating a collective commitment to this critical area. These partners include the American Osteopathic Association, Association of Cancer Care Centers, Boston Children’s Hospital, Carey, Carna Health, Google for Health, Mass General Brigham, the National Health Council, Stanford Medicine Department of Pediatrics, Swept AI, Talamel Health Technologies, UC Irvine Institute for Future Health, and Visana Health. DiMe is actively inviting additional organizations to participate as the initiative moves into its execution phase.
Broader Context and Future Vision
The launch of this initiative is timely, coinciding with increasing policy emphasis from regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC). These agencies have highlighted the necessity for interoperable, patient-centered digital tools and clearer expectations regarding the governance, accountability, and performance monitoring of AI as it becomes more integrated into healthcare delivery.
This initiative represents the first of DiMe’s planned AI projects for 2026, with another significant undertaking focused on operationalizing AI governance expected to launch later this quarter. DiMe, as a global non-profit organization, is dedicated to advancing the safe, effective, equitable, and ethical use of digital technologies to redefine healthcare and ultimately improve lives. Through its collaborative efforts and evidence-based frameworks, DiMe aims to accelerate the responsible digitization of healthcare to optimize human health.
Frequently Asked Questions (FAQ)
- What is the new initiative launched by DiMe?
- The Digital Medicine Society (DiMe) recently launched a new initiative titled “Scaling Trusted, High-Impact AI Care Navigation.”
- When was this initiative announced?
- The initiative was announced on January 9, 2026.
- What is the primary goal of the initiative?
- The primary goal is to accelerate the responsible adoption of AI-enabled care navigation at scale in response to how patients are already using AI to navigate care.
- Who are the key partners involved in this initiative?
- Intel is a Title Sponsor, and other founding partners include the American Osteopathic Association, Association of Cancer Care Centers, Boston Children’s Hospital, Carey, Carna Health, Google for Health, Mass General Brigham, the National Health Council, Stanford Medicine Department of Pediatrics, Swept AI, Talamel Health Technologies, UC Irvine Institute for Future Health, and Visana Health.
- What is the foundation of this new project?
- The project builds upon DiMe’s AI in Healthcare Playbook, which provides a roadmap for AI adoption and scale in U.S. care delivery.
- What specific problem does the initiative address?
- It addresses the patient navigation crisis and focuses on care navigation as a critical area for patient impact, especially given how patients are already using AI to navigate care.
Key Features of the “Scaling Trusted, High-Impact AI Care Navigation” Initiative
| Feature | Description | Scope |
|---|---|---|
| Core Objective | To scale trusted, high-impact AI care navigation. | Nationwide |
| Driving Force | Response to how patients are already using AI to navigate care. | Nationwide |
| Key Partner | Intel serves as a Title Sponsor. | Nationwide |
| Foundational Resource | Builds on DiMe’s AI in Healthcare Playbook. | U.S. care delivery |
| Problem Addressed | Focuses on the patient navigation crisis and impacts on patients. | Nationwide |
| Multi-stakeholder Collaboration | Convenes leaders from technology, healthcare delivery, patient advocacy, life sciences, and policy. | Nationwide |
| Output Goal | Define standards and evidence for AI-enabled care navigation. | Nationwide |
| Long-term Vision | First of DiMe’s 2026 AI projects, with future initiatives like operationalizing AI governance planned. | Nationwide |
Deeper Dive: News & Info About This Topic
CheckedUp Appoints Lyndi Hirsch as Chief Marketing Officer
Johnson County Launches New Patient Advocacy Line for Inmates’ Families
JDL Access Launches Access Bridge™ Enterprise Case Management Platform
JDL Access Launches Access Bridge™ for Patient Management
Healthcare Professionals Recognized with Legacy Award
Philadelphia Launches New Commerce Case Management Program
Virginia Advocates Push for Sickle Cell Patient Self-Advocacy
DiMe Launches Initiative to Enhance AI in Patient Care Navigation
Global Medical Case Management Market Predicted to Grow
The Dynamic Role of Case Management in Healthcare